Pune, India -- (SBWIRE) -- 10/03/2018 -- Avascular Necrosis Market - Overview
The avascular necrosis market is projected to increase at a CAGR of 6.58 percent during the forecast period (2018-2024) and is projected to reach valuation of USD 1.12 Bn by 2024.The avascular necrosis market globally is motivated by the growing occurrence of bone diseases such as osteoarthritis and osteoporosis together with the mounting cases of alcohol abuse and steroids, and implementation of the medication over surgery by the patients.
Request for Sample Report at https://www.marketresearchfuture.com/sample_request/6131
However, strict regulatory requirements and lack of awareness in a majority of the population may curb the progress of the market in the forecast period.
Competitive Tracking:
In due course of market study, key market-leading players were identified and analyzed including players such as Sanofi, Boehringer Ingelheim, Merck KGaA, Eli Lilly and company, Medtronics Plc, and Pfizer Inc.
Other notable players included are Bayer AG, Bristol-Myers Squibb, Zimmer Biomet Holdings, and Integra LifeSciences Corporation among others.
Although entry for small players is restrictive, ongoing innovations and development of relevant and effective treatment are some of the strategies employed by market players to expand market share.
Avascular Necrosis Market - Regional Analysis:
The Americas lead the global market for avascular necrosis due to the presence of various reputable market leaders and the technological advancements in diagnostics in the region. Countries such as U.S. and Canada are leading growth for the Americas. The second largest regional market segment belongs to Europe, due to the presence of a well-developed healthcare sector with favorable policies regarding research and development.
The Asia-Pacific is expected to be the fastest growing market for AVN due to the presence of a vast population with an increased rate of occurrence for osteonecrosis. Moreover, manufacturing of medical devices has shifted prominently to this region due to the ease in availability of cheap labor costs and lower investments in necessary infrastructure.
Avascular Necrosis Market - Segmental Analysis:
The segments on the basis of type, site, diagnosis, treatment, end-user, and region are used for the segmentation of the avascular necrosis market globally. By type, the market has been segmented non-trauma related avascular necrosis (AVN) and into trauma-related avascular necrosis (AVN).
The non-trauma related avascular necrosis segment presently is credited for the major market share and is expected to continue to be extremely productive throughout the assessment period. By site, the segmentation of the market includes knee, hip bone, shoulder, and other. In the year 2017, the hip bone segment was worth USD 508 Mn approximately.
By diagnosis, the market has been segmented into biopsy and imaging. The imaging segment at present is attributable for the biggest market share in the year 2017. The treatment segment of the market has comprises of electrical stimulation, medication, gene therapy, and surgery. Among these segments, the oncology segment is anticipated to develop with the peaking CAGR percent during the forecast period. The end user segment the market has been segmented into diagnostic centers, hospitals & clinics, and ambulatory surgical centers. The hospitals & clinics will probably retain its top position by the end of 2024.
Major TOC of Avascular Necrosis Market Research Report – Forecast to 2024:
1 Executive Summary
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Avascular Necrosis Market, by Type
7 Global Avascular Necrosis Market, by Site
8 Global Avascular Necrosis Market, by Diagnosis
9 Global Avascular Necrosis Market, by Treatment
10 Global Avascular Necrosis Market, by End-User
11 Global Avascular Necrosis Market, by Region
12 Competitive Landscape
13 Company Profiles
14 Conclusion
15 Appendix
Check Discount at https://www.marketresearchfuture.com/check-discount/6131
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com